Thrombosis Across Female‐Specific Malignancies: From Chemotherapy‐Driven Risk to Prophylaxis and Drug Interactions
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Maryam Aghakouchakzadeh, Hessam Kakavand, Anne J. Goldberg, Melissa Accordino, Meghna Trivedi, Jayant K. Raikhelkar, Azita H. Talasaz |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2026
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Cancer Treatment Modalities and Female Fertility Preservation
por: Seonga Song, et al.
Publicado: (2026)
por: Seonga Song, et al.
Publicado: (2026)
Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
por: Eugene Jeong, et al.
Publicado: (2025)
por: Eugene Jeong, et al.
Publicado: (2025)
Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
por: Youjun Chen, et al.
Publicado: (2025)
por: Youjun Chen, et al.
Publicado: (2025)
Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
por: William L. Baker, et al.
Publicado: (2026)
por: William L. Baker, et al.
Publicado: (2026)
Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
por: Amy Broadwater, et al.
Publicado: (2026)
por: Amy Broadwater, et al.
Publicado: (2026)
Synthetic Data–Driven Early Prediction Framework for Acute Kidney Injury in Patients Receiving Vancomycin and Ceftazidime/Avibactam
por: Maryam Ramazani, et al.
Publicado: (2025)
por: Maryam Ramazani, et al.
Publicado: (2025)
Probiotic Supplementation as an Adjuvant Therapy in Pediatric Drug‐Resistant Epilepsy: A Double‐Blind Placebo‐Controlled Trial
por: Amira R. Rashdan, et al.
Publicado: (2026)
por: Amira R. Rashdan, et al.
Publicado: (2026)
Kidney Damage Biomarkers: A Missing Piece of the Diagnostic and Management Puzzle for Acute Drug‐Related Kidney Diseases
por: Sandra L. Kane‐Gill
Publicado: (2025)
por: Sandra L. Kane‐Gill
Publicado: (2025)
Correlation Between Analgesic and Sedative Drug Withdrawal and Salivary Cortisol Levels in Children in PICUs : A Prospective Cohort Study
por: Yaping Zhan, et al.
Publicado: (2025)
por: Yaping Zhan, et al.
Publicado: (2025)
DILIConsult : A Multi‐Agent Large Language Model Framework for Evaluating Drug‐Induced Liver Injury in ICU Settings
por: Alfred Zheng Ting Ho, et al.
Publicado: (2026)
por: Alfred Zheng Ting Ho, et al.
Publicado: (2026)
Development and Validation of a Time‐Dependent Nomogram for Predicting Hematological Toxicity Risk During Linezolid Therapy in Drug‐Resistant Tuberculosis
por: Wenqiang Zhou, et al.
Publicado: (2026)
por: Wenqiang Zhou, et al.
Publicado: (2026)
Updates in chronic kidney disease management: A systematic review
por: Amina Ammar, et al.
Publicado: (2025)
por: Amina Ammar, et al.
Publicado: (2025)
Developing a Statistical Modeling‐Based Machine Learning Approach for Capturing Drug Dosing Using a Proton Pump Inhibitor Case
por: Amanda Massmann, et al.
Publicado: (2025)
por: Amanda Massmann, et al.
Publicado: (2025)
ECLIPSES: Early initiation of sodium glucose cotransporter‐2 inhibitors for cardiovascular protection in patients with type 2 diabetes following acute coronary syndrome and subsequent coronary artery bypass graft surgery
por: Lena Makortoff, et al.
Publicado: (2024)
por: Lena Makortoff, et al.
Publicado: (2024)
Antiviral influenza treatments and hemorrhage‐related adverse events in the United States Food and Drug Administration Adverse Event Reporting System (FAERS) database
por: Jyotirmoy Sarker, et al.
Publicado: (2024)
por: Jyotirmoy Sarker, et al.
Publicado: (2024)
Identifying Pediatric Drug Safety Knowledge Gaps: An Integrated Approach Leveraging Real‐World Data, a Biomedical Knowledge Base, and Postmarketing Surveillance Data
por: Saurabh Rahurkar, et al.
Publicado: (2025)
por: Saurabh Rahurkar, et al.
Publicado: (2025)
Correction to “International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy, Cystic Fibrosis Foundation, European Society of Clinical Microbiology and Infectious Diseases, Infectious Diseases Society of America, Society of Critical Care Medicine, and Society of Infectious Diseases Pharmacists”
Publicado: (2024)
Publicado: (2024)
A Multicenter, Open‐Label Study to Assess the Safety of Nebulized Tissue Plasminogen Activator for the Acute Treatment of Pediatric Plastic Bronchitis: The PLATyPuS Trial
por: Kathleen A. Stringer, et al.
Publicado: (2025)
por: Kathleen A. Stringer, et al.
Publicado: (2025)
Combination eravacycline therapy for ventilator‐associated pneumonia due to carbapenem‐resistant Acinetobacter baumannii in patients with COVID‐19: A case series
por: Melissa N. W. Jackson, et al.
Publicado: (2024)
por: Melissa N. W. Jackson, et al.
Publicado: (2024)
Correction to “Relationship of the Revised Anticholinergic Drug Scale With Cultured Cell‐Based Serum Anticholinergic Activity and Cognitive Measures in Older Adults With Mild Cognitive Impairment or Remitted Depression”
Publicado: (2025)
Publicado: (2025)
“Comment on ‘international consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the infectious diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists’”
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)
por: Carlos Augusto Espinoza Cobeñas
Publicado: (2024)
Aspirin Deprescribing Interventions for Primary Prevention: A Systematic Review and Proposed Guidance for Deprescribing
por: Alison Lobkovich, et al.
Publicado: (2026)
por: Alison Lobkovich, et al.
Publicado: (2026)
Response to comment on “International consensus recommendations for the use of prolonged‐infusion β‐lactams endorsed by the American College of Clinical Pharmacy (ACCP), the British Society for Antimicrobial Chemotherapy (BSAC), the Cystic Fibrosis Foundation (CFF), the European Society of Clinical Microbiology and Infectious Diseases (ESCMID), the Infectious Diseases Society of American (IDSA), the Society of Critical Care Medicine (SCCM), and the Society of Infectious Diseases Pharmacists”
por: Lisa T. Hong, et al.
Publicado: (2024)
por: Lisa T. Hong, et al.
Publicado: (2024)
Genome‐wide associations with metabolic syndrome among UK Biobank participants reporting use of second‐generation antipsychotics
por: Nihal El Rouby, et al.
Publicado: (2025)
por: Nihal El Rouby, et al.
Publicado: (2025)
Consensus recommendations for use of long‐acting antiretroviral medications in the treatment and prevention of HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy, Canadian HIV and Viral Hepatitis Pharmacists Network, European AIDS Clinical Society, and Society of Infectious Diseases Pharmacists
por: Elizabeth M. Sherman, et al.
Publicado: (2024)
por: Elizabeth M. Sherman, et al.
Publicado: (2024)
Consensus recommendations for the use of novel antiretrovirals in persons with HIV who are heavily treatment‐experienced and/or have multidrug‐resistant HIV‐1: Endorsed by the American Academy of HIV Medicine, American College of Clinical Pharmacy
por: David B. Cluck, et al.
Publicado: (2024)
por: David B. Cluck, et al.
Publicado: (2024)
Evaluation of methotrexate Pharmacogenomic variation to predict acute neurotoxicity in children with acute lymphoblastic leukemia
por: Rachel D. Harris, et al.
Publicado: (2024)
por: Rachel D. Harris, et al.
Publicado: (2024)
Vancomycin: An analysis and evaluation of eight population pharmacokinetic models for clinical application in general adult population
por: Alexandre Duong, et al.
Publicado: (2024)
por: Alexandre Duong, et al.
Publicado: (2024)
Aztreonam–avibactam: The dynamic duo against multidrug‐resistant gram‐negative pathogens
por: Mohammed Al Musawa, et al.
Publicado: (2024)
por: Mohammed Al Musawa, et al.
Publicado: (2024)
Response to comment on “Intravenous ketamine successfully treats treatment‐resistant catatonia in schizophrenia: A case report”
por: Atif Siddiqui
Publicado: (2025)
por: Atif Siddiqui
Publicado: (2025)
Managing attention‐deficit/hyperactivity disorder in a breastfeeding mother: A case report
por: Jiwon Kim, et al.
Publicado: (2025)
por: Jiwon Kim, et al.
Publicado: (2025)
Effect of proton pump inhibitors versus histamine‐2 receptor antagonists on acute kidney injury in septic patients at high risk for developing stress ulcers
por: Hua‐Ping Fan, et al.
Publicado: (2024)
por: Hua‐Ping Fan, et al.
Publicado: (2024)
Pharmacokinetic and Pharmacodynamic Principles and Concepts Remain Relevant in the Era of Artificial Intelligence and Machine Learning
por: Keith A. Rodvold
Publicado: (2026)
por: Keith A. Rodvold
Publicado: (2026)
Cross‐titration from risperidone to clozapine utilizing clozapine serum concentrations: A case report
por: Nicolette Centanni, et al.
Publicado: (2025)
por: Nicolette Centanni, et al.
Publicado: (2025)
Association of Pneumonia, Fracture, Metabolic, and Renal Events With Long‐Term Proton Pump Inhibitor Use in Patients With Chronic Kidney Disease
por: Yi‐Fan Chien, et al.
Publicado: (2025)
por: Yi‐Fan Chien, et al.
Publicado: (2025)
In Search of Big Beautiful Biomarkers
por: C. Lindsay DeVane
Publicado: (2025)
por: C. Lindsay DeVane
Publicado: (2025)
Evaluation of hyponatremia among older adults exposed to selective serotonin reuptake inhibitors and thiazide diuretics
por: Trisha Matsuura, et al.
Publicado: (2025)
por: Trisha Matsuura, et al.
Publicado: (2025)
Update on the clinical applications of SGLTis: Insight to benefits beyond hypoglycemic and cardiorenal protection
por: Shibing Tao, et al.
Publicado: (2024)
por: Shibing Tao, et al.
Publicado: (2024)
Oral β‐Lactams for Complicated Urinary Tract Infections: A Systematic Review and Point‐Counterpoint Comparison With Trimethoprim/Sulfamethoxazole and Fluoroquinolones
por: Ashlan J. Kunz Coyne, et al.
Publicado: (2026)
por: Ashlan J. Kunz Coyne, et al.
Publicado: (2026)
Current and Emerging Pharmacologic Therapies for Diabetic Retinopathy
por: Jennifer N. Clements, et al.
Publicado: (2026)
por: Jennifer N. Clements, et al.
Publicado: (2026)
Ejemplares similares
-
Cancer Treatment Modalities and Female Fertility Preservation
por: Seonga Song, et al.
Publicado: (2026) -
Association of Omeprazole‐Related Myopathy With Drug–Drug and Drug–Gene Interactions Involving CYP2C19 and CYP3A4: A Nested Case–Control Study
por: Eugene Jeong, et al.
Publicado: (2025) -
Drug–Drug Interactions and Combination Therapy Strategies of Amiodarone With Digoxin, Rivaroxaban, and Phenytoin Assessed by Physiologically Based Pharmacokinetic Modeling
por: Youjun Chen, et al.
Publicado: (2025) -
Harnessing the Power of Artificial Intelligence to Enhance Drug Therapy Research
por: William L. Baker, et al.
Publicado: (2026) -
Pharmaceutical Considerations for Oncology Risk, Screening, and Drug Dosing in the Transgender Population
por: Amy Broadwater, et al.
Publicado: (2026)